Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
Recruiting · NCT06643416 · Registry updated 2024-10-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia | Infections, Skin and Connective Tissue Diseases, nail disorder, paronychia, skin disorder, skin disorder caused by infection | Recruiting | Phase 3 | 2024-10-18 | NCT06643416 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Queen Mary Hospital, Hong Kong | 41 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Queen Mary Hospital | Hong Kong | Hong Kong | 96 |